| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 8 |
| 1 | ALENDRONATE SODIUM | 7 |
| 2 | ADALIMUMAB | 6 |
| 3 | METHOTREXATE | 6 |
| 4 | METHOTREXATE SODIUM | 6 |
| 5 | ABATACEPT | 5 |
| 6 | CYCLOPHOSPHAMIDE | 4 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 9 | INTERFERON BETA-1A | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 1 | TAZAROTENE | 1 | 0.0008 |
| 2 | TERBINAFINE TABLETS 250 MG | 1 | 0.0008 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 4 | SARGRAMOSTIM | 1 | 0.0006 |
| 5 | PRUCALOPRIDE | 1 | 0.0004 |
| 6 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | ZINC SULFATE INJECTION, | 1 | 0.0003 |
| 8 | ZINC SULFATE INJECTION | 1 | 0.0003 |
| 9 | C1 ESTERASE INHIBITOR RECOMBINANT | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Cannabinoid [EPC] | 1 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |